Clinical trial
New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip…
NCT00074828 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00074828 |
|---|---|
| Title | New Oral Anticoagulant Therapy for the Prevention of Blood Clots Following Hip or Knee Replacement Surgery |
| Official title | A Comparison of the Oral Anticoagulant LY517717 Difumarate to Subcutaneous Enoxaparin for the Prevention of Venous Thromboembolic Events (VTE) Post-Total Hip Replacement (THR) and Post-Total Knee Replacement (TKR) Surgery |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Total Knee Replacement, Total Hip Replacement |
| Intervention type | Drug |
| Interventions | LY517717, enoxaparin |
| Enrollment | 511 |
| Start date | Dec 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Dec 23, 2003 |
| Last update posted | Mar 31, 2008 |
| Countries | Australia, Austria, Belgium, Czechia, Germany, Hungary, Italy, Poland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: